Прати
Rajiv Radhakrishnan
Rajiv Radhakrishnan
Yale University School of Medicine
Верификована је имејл адреса на yale.edu
Наслов
Навело
Навело
Година
Gone to pot–a review of the association between cannabis and psychosis
R Radhakrishnan, ST Wilkinson, DC D’Souza
Frontiers in psychiatry 5, 54, 2014
4902014
Suicide: an Indian perspective
R Radhakrishnan, C Andrade
Indian journal of psychiatry 54 (4), 304-319, 2012
3762012
Marijuana Legalization: Impact on Physicians and Public Health
ST Wilkinson, S Yarnell, R Radhakrishnan, SA Ball, DC D'Souza
Annual Review of Medicine, 2015
2682015
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
G Hindley, K Beck, F Borgan, CE Ginestet, R McCutcheon, D Kleinloog, ...
The Lancet Psychiatry 7 (4), 344-353, 2020
2342020
Hormonal treatments for major depressive disorder: state of the art
JB Dwyer, A Aftab, R Radhakrishnan, A Widge, CI Rodriguez, ...
American Journal of Psychiatry 177 (8), 686-705, 2020
2292020
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled …
DC D'Souza, J Cortes-Briones, G Creatura, G Bluez, H Thurnauer, ...
The Lancet Psychiatry, 2018
1732018
The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments
C Andrade, R Radhakrishnan
Indian journal of psychiatry 51 (1), 12-25, 2009
1732009
Human Laboratory Studies on Cannabinoids and Psychosis
M Sherif, R Radhakrishnan, DC D'Souza, M Ranganathan
Biological Psychiatry, 2016
1592016
Impact of cannabis use on the development of psychotic disorders
ST Wilkinson, R Radhakrishnan, DC D’Souza
Current addiction reports 1, 115-128, 2014
1552014
Prayer and healing: A medical and scientific perspective on randomized controlled trials
C Andrade, R Radhakrishnan
Indian journal of psychiatry 51 (4), 247-253, 2009
1482009
Association of cannabis use during adolescence with neurodevelopment
MD Albaugh, J Ottino-Gonzalez, A Sidwell, C Lepage, A Juliano, ...
JAMA psychiatry 78 (9), 1031-1040, 2021
1392021
Reduced brain cannabinoid receptor availability in schizophrenia
M Ranganathan, J Cortes-Briones, R Radhakrishnan, H Thurnauer, ...
Biological psychiatry 79 (12), 997-1005, 2016
1292016
Grey matter volume differences associated with extremely low levels of cannabis use in adolescence
C Orr, P Spechler, Z Cao, M Albaugh, B Chaarani, S Mackey, D D'Souza, ...
Journal of Neuroscience 39 (10), 1817-1827, 2019
1182019
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
ST Wilkinson, R Radhakrishnan, DC D'Souza
Journal of Clinical Psychiatry 77 (8), 1050-1064, 2016
1042016
Acute effects of THC on time perception in frequent and infrequent cannabis users
RA Sewell, A Schnakenberg, J Elander, R Radhakrishnan, A Williams, ...
Psychopharmacology 226, 401-413, 2013
1032013
Thyroid dysfunction in major psychiatric disorders in a hospital-based sample.
R Radhakrishnan, S Calvin, J Singh, B Thomas, K Srinivasan
Indian Journal of Medical Research 138, 888-893, 2013
1022013
The Link Between the Immune System, Environment, and Psychosis
R Radhakrishnan, M Kaser, S Guloksuz
Schizophrenia Bulletin, 2017
1002017
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study
DC D'souza, R Radhakrishnan, E Perry, S Bhakta, NM Singh, R Yadav, ...
Neuropsychopharmacology 38 (3), 492-503, 2013
902013
Evidence that environmental and familial risks for psychosis additively impact a multidimensional subthreshold psychosis syndrome
LK Pries, S Guloksuz, M Ten Have, R De Graaf, S Van Dorsselaer, ...
Schizophrenia Bulletin 44 (4), 710-719, 2018
832018
In vivo evidence of lower synaptic vesicle density in schizophrenia
R Radhakrishnan, PD Skosnik, M Ranganathan, M Naganawa, ...
Molecular Psychiatry 26 (12), 7690-7698, 2021
822021
Систем тренутно не може да изврши ову радњу. Пробајте поново касније.
Чланци 1–20